These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. After fen-phen. Cowley G; Springen K Newsweek; 1997 Sep; 130(13):46-8. PubMed ID: 10173270 [No Abstract] [Full Text] [Related]
9. Serial echocardiographic and clinical evaluation of valvular regurgitation before, during, and after treatment with fenfluramine or dexfenfluramine and mazindol or phentermine. Ryan DH; Bray GA; Helmcke F; Sander G; Volaufova J; Greenway F; Subramaniam P; Glancy DL Obes Res; 1999 Jul; 7(4):313-22. PubMed ID: 10440587 [TBL] [Abstract][Full Text] [Related]
10. The treatment of obesity with drugs. Hirsch J Am J Clin Nutr; 1998 Jan; 67(1):2-4. PubMed ID: 9440366 [No Abstract] [Full Text] [Related]
11. [Drug-clinics. The hue and cry over central appetite suppressants!]. Scheen AJ Rev Med Liege; 1997 Sep; 52(9):613-5. PubMed ID: 9441348 [No Abstract] [Full Text] [Related]
12. With new diet drug, challenge is weighing patient demand and potential benefit. Jones L Ann Intern Med; 1996 Aug; 125(4):I58. PubMed ID: 9446497 [No Abstract] [Full Text] [Related]
13. Anorectic therapy and valvular heart disease: a reappraisal. Silvestry FE; St John Sutton M Eur Heart J; 1999 Jul; 20(13):917-20. PubMed ID: 10361039 [No Abstract] [Full Text] [Related]
14. Fen/phen and valvular heart disease: if it sounds too bad to be true, perhaps it isn't. Schiller NB J Am Coll Cardiol; 1999 Oct; 34(4):1159-62. PubMed ID: 10520806 [No Abstract] [Full Text] [Related]
16. Use of dexfenfluramine, fenfluramine and phentermine and the risk of stroke. Derby LE; Myers MW; Jick H Br J Clin Pharmacol; 1999 May; 47(5):565-9. PubMed ID: 10336582 [TBL] [Abstract][Full Text] [Related]
17. Valvular abnormalities and cardiovascular status following exposure to dexfenfluramine or phentermine/fenfluramine. Gardin JM; Schumacher D; Constantine G; Davis KD; Leung C; Reid CL JAMA; 2000 Apr; 283(13):1703-9. PubMed ID: 10755496 [TBL] [Abstract][Full Text] [Related]
18. Clinical and echocardiographic follow-up of patients previously treated with dexfenfluramine or phentermine/fenfluramine. Gardin JM; Weissman NJ; Leung C; Panza JA; Fernicola D; Davis KD; Constantine GD; Reid CL JAMA; 2001 Oct 24-31; 286(16):2011-4. PubMed ID: 11667938 [TBL] [Abstract][Full Text] [Related]
19. Low prevalence of valvular heart disease in 226 phentermine-fenfluramine protocol subjects prospectively followed for up to 30 months. Burger AJ; Sherman HB; Charlamb MJ; Kim J; Asinas LA; Flickner SR; Blackburn GL J Am Coll Cardiol; 1999 Oct; 34(4):1153-8. PubMed ID: 10520805 [TBL] [Abstract][Full Text] [Related]
20. Diet drugs and cardiac valvulopathy: a survey of dental patients. Rudin R; Carpenter W J Calif Dent Assoc; 2000 Dec; 28(12):955-9. PubMed ID: 11323951 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]